The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of SPB, SVXY, MHLD and DPLO
NEW YORK, March 28, 2019 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) (NYSE: SPB) Class Period: June 14, 2016 to April 25, 2018 Lead Plaintiff Deadline: May 6, 2019
The lawsuit alleges that Spectrum Brands Legacy, Inc. (f/k/a Spectrum Brands Holdings, Inc.) made materially false and/or misleading statements and/or failed to disclose that: (i) Spectrum had been self-inflicting the operational issues at its Ohio and Kansas facilities; (ii) these operational issues were, in fact, recurring in nature; (iii) these operational issues would continuously impact production, shipping levels and sales; and (iv) as a result of the foregoing, the Company’s financial statements were materially false and misleading at all relevant times.
Get additional information about the SPB lawsuit: http://www.kleinstocklaw.com/pslra-1/spectrum-brands-holdings-inc-loss-submission-form?wire=3
ProShares Short VIX Short-Term Futures (NYSEArca: SVXY) Class Period: Investors in ProShares Short VIX Short-Term Futures ETF pursuant to the May 15, 2017 Registration Statement and/or between May 15, 2017 and February 5, 2018 Lead Plaintiff Deadline: April 1, 2019
According to the complaint in the Registration Statement and during the Class Period, defendants made false and misleading statements and/or failed to disclose adverse information regarding the risks of investing in the Fund. Specifically, the Registration Statement failed to disclose that the Fund was threatened with catastrophic losses as a result of the Fund’s flawed design and the low-volatility environment and acute liquidity risks that existed during the Class Period. In addition, during the Class Period defendants made similar false and misleading statements in numerous financial reports and draft prospectuses and registration statements filed with the SEC.
Get additional information about the SVXY lawsuit: http://www.kleinstocklaw.com/pslra-1/proshares-short-vix-short-term-futures-loss-submission-form?wire=3
Maiden Holdings, Ltd. (NASDAQGS: MHLD) Class Period: March 4, 2014 to November 9, 2018 Lead Plaintiff Deadline: April 12, 2019
The complaint alleges that during the Class Period, defendants misrepresented the quality and nature of Maiden’s underwriting and risk management policies and practices and the risks of its reinsurance portfolio. In particular, defendants misleadingly claimed that they were subjecting AmTrust’s insurance portfolio to robust analysis and cross-checks to ensure that the Company had appropriately priced the risk of reinsuring AmTrust’s insurance portfolio. In truth, the Company had failed to employ sufficient underwriting and risk management protocols and had largely abdicated its responsibility to ensure that its AmTrust Reinsurance segment priced policies commensurate with the risk assumed by the Company.
Get additional information about the MHLD lawsuit: http://www.kleinstocklaw.com/pslra-1/maiden-holdings-ltd-loss-submission-form?wire=3
Diplomat Pharmacy, Inc. (NYSE: DPLO) Class Period: February 26, 2018 to February 21, 2019 Lead Plaintiff Deadline: April 25, 2019
The lawsuit alleges that throughout the class period, Diplomat Pharmacy, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) Diplomat had downplayed its success in integrating and growing its PBM business, which included LDI Integrated and National Pharmaceutical, two companies Diplomat had acquired in late 2017; (2) consequently, Diplomat would need to record a non-cash impairment charge upwards of approximately $630 million relating to its PBM business and these 2017 acquisitions; (3) due to the foregoing, Diplomat would withdraw its preliminary 2019 full-year outlook issued less than seven weeks prior; and (4) as a result, defendants’ statements about Diplomat’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Get additional information about the DPLO lawsuit: http://www.kleinstocklaw.com/pslra-1/diplomat-pharmacy-inc-loss-submission-form?wire=3
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.